REGN logo

REGN
Regeneron Pharmaceuticals, Inc.

17,568
Mkt Cap
$96.07B
Volume
84,788.00
52W High
$800.99
52W Low
$476.49
PE Ratio
16.82
REGN Fundamentals
Price
$736.04
Prev Close
$701.87
Open
$722.96
50D MA
$608.00
Beta
0.60
Avg. Volume
1.11M
EPS (Annual)
$38.34
P/B
2.39
Rev/Employee
$940,156.23
Loading...
Loading...
News
all
press releases
Seizert Capital Partners LLC Has $45.14 Million Stock Position in Regeneron Pharmaceuticals, Inc. $REGN
Seizert Capital Partners LLC raised its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Intrust Bank NA Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN
Intrust Bank NA cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 48.3% during the second quarter, according to the company in its most recent Form 13F...
MarketBeat·3h ago
News Placeholder
Nomura Asset Management Co. Ltd. Trims Stake in Regeneron Pharmaceuticals, Inc. $REGN
Nomura Asset Management Co. Ltd. lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 40.0% during the second quarter, according to its most recent filing...
MarketBeat·3h ago
News Placeholder
Rockefeller Capital Management L.P. Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN
Rockefeller Capital Management L.P. decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 56.2% during the second quarter, according to its most recent...
MarketBeat·4h ago
News Placeholder
REGN Factor-Based Stock Analysis - Benjamin Graham
Below is Validea's guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow, REGN rates highest using our Value Investor model based on the published...
Nasdaq News: Markets·20h ago
News Placeholder
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Raiffeisen Bank International AG
Raiffeisen Bank International AG reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 2.7% during the 2nd quarter, according to its most recent filing with the...
MarketBeat·1d ago
News Placeholder
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Citigroup Inc.
Citigroup Inc. grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 0.2% in the second quarter, according to its most recent filing with the Securities and...
MarketBeat·1d ago
News Placeholder
Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by ARS Investment Partners LLC
ARS Investment Partners LLC grew its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 222.0% in the second quarter, according to its most recent disclosure with the Securities...
MarketBeat·1d ago
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Has $55.94 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN
Universal Beteiligungs und Servicegesellschaft mbH lowered its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 32.2% during the second quarter, according to the...
MarketBeat·2d ago
News Placeholder
SG Americas Securities LLC Has $8.42 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN
SG Americas Securities LLC decreased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN - Free Report) by 76.4% during the 2nd quarter, according to the company in its most recent...
MarketBeat·2d ago

Latest REGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.